Down's syndrome with alzheimer's disease-like pathology: What can it teach us about the amyloid cascade hypothesis?

International Journal of Alzheimer's Disease

Volumn , Issue , 2010, Pages

  De Courten Myers, Gabrielle M ^b   Bakkar, Rania M ^a   Luo, Guangju ^b   Webb, Thomas A ^b   Crutcher, Keith A ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; BRAIN; CASE REPORT; DEATH; DEEP VEIN THROMBOSIS; DEMENTIA; DOWN SYNDROME; DYSPHAGIA; FECES INCONTINENCE; GAIT DISORDER; GAZE PARALYSIS; GENOTYPE; HUMAN; INTERVERTEBRAL DISK HERNIA; LAMINECTOMY; MALE; MENTAL DEFICIENCY; NEUROFILAMENT; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROTEIN METABOLISM; SPASTICITY; SPINAL CORD COMPRESSION; TRISOMY 21; ULTRASOUND; URINE INCONTINENCE; VERTEBRAL CANAL STENOSIS;

EID: 77955963776     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2010/175818     Document Type: Article

References (32)

1. Menendez M., Down syndrome, Alzheimer's disease and seizures Brain Development 2005 27 4 246 252
2. Schweber M. S., Alzheimer's disease and Down syndrome Progress in Clinical and Biological Research 1989 317 247 267
3. Gyure K. A., Durham R., Stewart W. F., Smialek J. E., Troncoso J. C., Intraneuronal A -amyloid precedes development of amyloid plaques in Down syndrome Archives of Pathology and Laboratory Medicine 2001 125 4 489 492
4. Octave J.-N., The amyloid peptide and its precursor in Alzheimer's disease Reviews in the Neurosciences 1995 6 4 287 316
5. Evin G., Weidemann A., Biogenesis and metabolism of Alzheimer's disease A amyloid peptides Peptides 2002 23 7 1285 1297
6. Vardy E. R., Catto A. J., Hooper N. M., Proteolytic mechanisms in amyloid- metabolismml: therapeutic implications for Alzheimer's disease Trends in Molecular Medicine 2005 11 10 464 472
7. Barbiero L., Benussi L., Ghidoni R., BACE-2 is overexpressed in Down's syndrome Experimental Neurology 2003 182 2 335 345
8. Cheon M. S., Dierssen M., Kim S. H., Lubec G., Protein expression of BACE1, BACE2 and APP in Down syndrome brains Amino Acids 2008 35 2 339 343
9. Lee H. G., Zhu X., Castellani R. J., Nunomura A., Perry G., Smith M. A., Amyloid- in Alzheimer disease. The null versus the alternate hypotheses Journal of Pharmacology and Experimental Therapeutics 2007 321 3 823 829
10. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis Science 1992 256 5054 184 185
11. Ringman J. M., Diaz-Olavarrieta C., Rodriguez Y., Neuropsychological function in nondemented carriers of presenilin-1 mutations Neurology 2005 65 4 552 558
12. Belza M. G., Urich H., Cerebral amyloid angiopathy in Down's syndrome Clinical Neuropathology 1986 5 6 257 260
13. Mirra S. S., Heyman A., McKeel D., The consortium to establish a registry for Alzheimer's disease (CERAD) part II: standardization of the neuropathologic assessment of Alzheimer's disease Neurology 1991 41 4 479 486
14. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Tredici K., Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry Acta Neuropathologica 2006 112 4 389 404
15. Braak H., Rb U., Jansen Steur E. N. H., Del Tredici K., de Vos R. A. I., Cognitive status correlates with neuropathologic stage in Parkinson disease Neurology 2005 64 8 1404 1410
16. Rumble B., Retallack R., Hilbich C., Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease The New England Journal of Medicine 1989 320 22 1446 1452
17. McKenzie J. E., Roberts G. W., Royston M. C., Comparative investigation of neurofibrillary damage in the temporal lobe in Alzheimer's disease, Down's syndrome and dementia pugilistica Neurodegeneration 1996 5 3 259 264
18. Sapra M., Kim K. Y., Anti-amyloid treatments in Alzheimer's disease Recent Patents on CNS Drug Discovery 2009 4 2 143 148
19. Lee H. G., Casadesus G., Zhu X., Takeda A., Perry G., Smith M. A., Challenging the amyloid cascade hypothesis: senile plaques and amyloid- as protective adaptations to Alzheimer disease Annals of the New York Academy of Sciences 2004 1019 1 4
20. Williams M., Progress in Alzheimer's disease drug discovery: an update Current Opinion in Investigational Drugs 2009 10 1 23 34
21. Doody R. S., Gavrilova S. I., Sano M., Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study The Lancet 2008 372 9634 207 215
22. Sullivan M. G., Dimebon's effect may challenge amyloid theory Clinical Neurology News 2009 5 7 11
23. Kowalska A., Genetic basis of neurodegeneration in familial Alzheimer's disease Polish Journal of Pharmacology 2004 56 2 171 178
24. Siman R., Reaume A. G., Savage M. J., Preselinin-1 P264L knock-in mutation: differential effects on a production, amyloid deposition, and neuronal vulnerability The Journal of Neuroscience 2000 20 23 8717 8726
25. Corder E. H., Lannfelt L., Bogdanovic N., Fratiglioni L., Mori H., The role of APOE polymorphisms in late-onset dementias Cellular and Molecular Life Sciences 1998 54 9 928 934
26. Tsai M.-S., Tangalos E.G., Petersen R. C., Apolipoprotein E: risk factor for Alzheimer disease The American Journal of Human Genetics 1994 54 643 649
27. Zigman W. B., Jenkins E. C., Tycko B., Schupf N., Silverman W., Mortality is associated with apolipoprotein E 4 in nondemented adults with Down syndrome Neuroscience Letters 2005 390 2 93 97
28. Kirkitadze M. D., Kowalska A., Molecular mechanisms initiating amyloid -fibril formation in Alzheimer's disease Acta Biochimica Polonica 2005 52 2 417 423
29. Ingelsson M., Fukumoto H., Newell K. L., Early A accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain Neurology 2004 62 6 925 931
30. Standridge J. B., Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease Current Alzheimer Research 2006 3 2 95 108
31. Heinitz K., Beck M., Schliebs R., Perez-Polo J. R., Toxicity mediated by soluble oligomers of -amyloid(142) on cholinergic SN56.B5.G4 cells Neurochemistry 2006 98 6 1930 1945
32. Christensen D. Z., Schneider-Axmann T., Lucassen P. J., Bayer T. A., Wirths O., Accumulation of intraneuronal A correlates with ApoE4 genotype Acta Neuropathologica 119 5 555 566